Sustainable Medicines Manufacturing Innovation: CR&D Round 2

Innovate UK, part of UK Research and Innovation, will work with the Department of Health and Social Care (DHSC) to invest up to £7 million to support the development and adoption of sustainable technologies for the manufacturing of medicines.
Registration Details

05/10/2026 02/12/2026 11:00am
Award

Your project’s total eligible grant funding request must be between £500,000 and £1 million. This can cover up to 70% of costs depending on business size and project type.
Organisation

Innovate UK
Find out more and apply

Innovate UK, part of UK Research and Innovation (UKRI), will work with the Department of Health and Social Care (DHSC) to invest up to £7 million to support the technical development and commercial readiness of sustainable technologies for the manufacturing of medicines. This is subject to a sufficient number of high quality applications being received. This funding is part of the Sustainable Medicines Manufacturing Innovation programme.

Projects must be collaborative and must involve at least one UK registered SME.

The aim of this competition is to drive innovation in sustainable medicines manufacturing across three key pillars:

  • green chemistry
  • circularity
  • productivity and resource efficiency

These new manufacturing innovations are expected to support more environmentally sustainable manufacturing processes with significant and measurable improvements in at least one of the following areas:

  • productivity
  • waste reduction
  • emissions reduction
  • energy use reduction
  • resource efficiency

We define sustainable medicines manufacturing as the process of producing medicines in a manner that minimises environmental impact, conserves natural resources, and ensures economic and social sustainability. This approach focuses on reducing waste, energy consumption and emissions, while enhancing efficiency, safety, and cost effectiveness throughout the manufacturing lifecycle. It also includes the adoption of innovative technologies and practices that promote the long term viability of the medicines manufacturing industry.

Your proposal must consider your Commercial Readiness Levels (CRLs) and how this grant will enable you to progress both Technology Readiness Levels (TRLs) and CRLs towards a successful commercial end.

Our experience from similar competitions suggests that you could have a 15% chance of success.

  • To lead a collaborative project your organisation must be a UK registered:

    • business of any size
    • research and technology organisation (RTO)
    • catapult centre
    • not for profit organisation
    • public sector organisation
    • charity

    The consortium must contain at least one UK registered micro, small or medium sized enterprise (SME) claiming grant funding on this application.

    If the lead organisation is an RTO it must collaborate with two businesses (one SME, and one business of any size).

    To collaborate with the lead, your organisation must be one of the following UK registered:

    • business of any size
    • academic institution
    • charity
    • not for profit
    • public sector organisation
    • research and technology organisation (RTO)
    • catapult centre

    An eligible organisation can lead on no more than two applications. Any further applications by the same organisation as lead will be made ineligible.

    If not leading, an eligible organisation can collaborate in any number of applications.

  • Your project must:

    • have a grant funding request of between £500,000 and £1 million
    • last between 9 and 12 months
    • start by 1 April 2027
    • end by 31 March 2028

    Any organisation receiving funding must carry out its project work in the UK, intend to exploit the results in the UK, and spend most of the funding within the UK.

    No single organisation in the consortium can claim more than 70% of the total project costs.

    The grant funding can usually cover up to 70% of the total costs, depending on business size and project type; the maximum will be less for larger businesses or projects which are closer to market.

  • The aim of this competition is to drive innovation in sustainable medicines manufacturing across three key pillars:

    • green chemistry
    • circularity
    • productivity and resource efficiency

    You must also consider both critical enablers; regulations and measurements, standards and data.

    Proposals must include sustainability claims that are evidenced through baseline measurements and clearly defined metrics to quantify anticipated improvements.

    These new manufacturing innovations are expected to support more environmentally sustainable manufacturing processes with significant and measurable improvements in at least one of the following areas:

    • productivity
    • waste reduction
    • emissions reduction
    • energy use reduction
    • resource efficiency

    Funding must be used to invest in innovation to deliver across four key goals:

    • drive disruptive and novel technologies or processes in medicines manufacturing to optimise production efficiency, minimise waste and reduce emissions, aligning with global sustainability goals
    • facilitate the effective implementation of innovative solutions and promote their adoption across the medicines manufacturing sector, ensuring scalability and widespread utilisation
    • enhance the UK’s attractiveness as a prime location for investment in medicines manufacturing, thereby stimulating economic growth and enhancing resilience in the sector
    • strengthen the UK’s manufacturing innovation ecosystem through collaborative partnerships between academia, industry, and government entities, promoting knowledge exchange and collaborative initiatives to enhance sustainable manufacturing practices

    Your project must also consider how to overcome any regulatory barriers to adoption of your innovation, alongside approaches to capture data that support the measurement and reporting of sustainability indicators aligned with industry standards.

    Your project must involve technologies that are already at Technology Readiness Levels (TRLs) 6 or above and advance them by a minimum of two TRL levels, progressing towards deployment within a manufacturing environment.

    Your proposal must show how your project will improve the productivity, competitiveness and growth for at least one UK micro, small or medium sized enterprise (SME) involved in the project.

    You must be able to articulate your commercialisation plans and how this grant will support your journey to driving adoption.

  • We welcome proposals from collaborations across different sectors.

    Your project must address both critical enablers and focus on at least one of the following pillars:

    Pillar 1. Green chemistry

    For example:

    • biocatalysis, new chemocatalysis
    • flow chemistry
    • solvent free systems
    • sustainable solvents
    • biomanufacturing for active pharmaceutical ingredient (API), plastics and biopolymers
    • technology switches away from solid phase synthesis

    This is not an exhaustive list.

    Pillar 2. Circularity

    For example:

    • recycle and reuse of materials, for example, solvents, water, plastics, packaging
    • identify materials with potential for circularity

    This is not an exhaustive list.

    Pillar 3. Productivity and resource efficiency

    For example:

    • continuous processing​
    • process intensification
    • digital processing, digitalisation, automation or robotics.
    • utilise shared data to enable use of artificial intelligence and machine learning
    • analyse waste in the supply chain
    • streamline development processes​
    • reduction of energy use
    • increasing yield, productivity and efficiencies

    The lists above are not exhaustive.

    Skills and training can be considered alongside any of the three pillars.

    Enabler 1. Regulations

    Your project must identify regulatory challenges and propose solutions.

    Enabler 2. Measurements, data and standards

    Your project can align with emerging approaches, for example:

    • life cycle analysis (LCA)
    • carbon footprint reporting
    • demonstrating efficiency in resource efficiency and reduced emissions

    This is not an exhaustive list and proposals do not have to be restricted to these.

    We encourage proposals that align with national innovation and policy priorities, such as those set out in:

  • We are not funding projects that:

    • do not fit the scope or eligibility of this competition
    • are non-human medicines manufacturing
    • are medical device manufacturing
    • are infrastructure and facility design without appropriate demonstration
  • Innovate UK will hold an online briefing event at 3pm on Tuesday 13 October: click here for the joining link (Zoom required). A recording and slides will be available afterwards.

    If you would like help to find a collaboration partner, contact Innovate UK Business Connect’s Health team.

Innovate UK's application and funding process

If you need more information about how to apply, please read our funding support pages. For additional support, reach out to our team of innovation experts who are ready to help you navigate the application process and maximise your chances of success.

For more information

Application support and guidance

Accessibility and Inclusion

Innovate UK welcome and encourage applications from people of all backgrounds and are committed to making our application process accessible to everyone. This includes making reasonable adjustments, for people who have a disability or a long-term condition and face barriers applying to us.

Get in touch

If you have any questions about the scope requirements of this competition, email support@iuk.ukri.org or call 0300 321 4357.


Our phone lines are open from 9am to 5pm, Monday to Friday (excluding bank holidays).

Programme

This opportunity is part of Sustainable Medicines Manufacturing.

The Sustainable Medicines Manufacturing Innovation Programme will focus on innovation in sustainable medicines manufacturing to improve the manufacturing innovation ecosystem in the UK towards a sustainable future.

Find out more
Close

Connect with Innovate UK Business Connect

Join Innovate UK Business Connect's mailing list to receive updates on funding opportunities, events and to access Innovate UK Business Connect's deep expertise. Please check your email to confirm your subscription and select your area(s) of interest.